Thermo Fisher Scientific
Signal active
Investment Firm
Overview
Thermo Fisher Scientific is a provider of laboratory information management and scientific data systems. It aims to enable its customers to make the world healthier, cleaner, and safer. Whether its customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, they are here to support them.
Its global team delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.
Highlights
Founded
1956
Industry
Biotechnology
Employees
10001+
Investment
3
Lead Investment
1
Exits
undefined
Stages
Early Stage Venture
Investor Type
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Thermo Fisher Scientific, established in 1956 and headquartered in United States, North America., specializes in Early Stage Venture investments across Software, Virtual Reality, Hardware, Artificial Intelligence (AI), GPU, Venture Capital, FinTech, Angel Investment, Crowdfunding, Funding Platform. Their recent investments include NVIDIA, OurCrowd, Pfizer, WuXi Diagnostics, YF Capital. The highest investment round they participated in was $10.2B. Among their most notable exits are NVIDIA and OurCrowd. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Thermo Fisher Scientific has made 3 investments. Their most recent investment was on Feb 23, 2021, when WuXi Diagnostics raised $150.0M.
investments
3
Diversity investments
0
Lead investments
1
Number of exits
undefined
Investments
3
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Feb 23, 2021 | WuXi Diagnostics | Biotechnology | 150.0M |
| May 11, 2022 | - | - | null |
| Jul 17, 2024 | - | - | 80.0M |
Exits
0
Funding Timeline
Funding rounds
3
Investors
1
Funds
0
Funding Rounds
3
Thermo Fisher Scientific has raised 3 rounds. Their latest funding was raised on Jul 17, 2024 from a Series B - CytoReason round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Feb 23, 2021 | Series B - WuXi Diagnostics | - | 150.0M | - |
| May 11, 2022 | Corporate Round - Ionpath | - | 0 | - |
| Jul 17, 2024 | Series B - CytoReason | - | 80.0M | - |
Investors
5
Thermo Fisher Scientific is funded by 5 investor(s). National Grid Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
| - | No | Post-IPO Debt - Thermo Fisher Scientific | 736.1M |
| - | No | Post-IPO Debt - Thermo Fisher Scientific | 1294.7M |
National Grid | Yes | Grant - Thermo Fisher Scientific | 500.0K |
| - | No | Post-IPO Debt - Thermo Fisher Scientific | 2950.0M |
National GridFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.